subject area of
- Abciximab (ReoPro) removal during cardiopulmonary bypass with a hemoconcentrator Academic Article
- Bivalirudin vs heparin in percutaneous coronary intervention: A pooled analysis Academic Article
- Bridging antiplatelet therapy with cangrelor in patients undergoing cardiac surgery a randomized controlled trial Academic Article
- Comparison of bivalirudin versus heparin during percutaneous coronary intervention (the randomized evaluation of pci linking angiomax to reduced clinical events replace -1 trial) Academic Article
- Creatine kinase-mb elevation after coronary artery bypass grafting surgery in patients with non-st-segment elevation acute coronary syndromes predict worse outcomes: Results from four large clinical trials Academic Article
- Impact of body mass index on outcome after percutaneous coronary intervention (the obesity paradox) Academic Article
- Impact of clinical syndrome acuity on the differential response to 2 glycoprotein IIb/IIIa inhibitors in patients undergoing coronary stenting: the TARGET Trial Academic Article
- Impact of clopidogrel in patients with acute coronary syndromes requiring coronary artery bypass surgery: a multicenter analysis Academic Article
- Impact of female sex on outcome after percutaneous coronary intervention Academic Article
- Randomized, placebo-controlled trial of platelet glycoprotein iib/iiia blockade with primary angioplasty for acute myocardial infarction Academic Article
- Reduction in vascular access site bleeding in sequential abciximab coronary intervention trials Academic Article
- Safety and efficacy of cangrelor, an intravenous, short-acting platelet inhibitor in patients requiring coronary artery bypass surgery Academic Article
- Safety of abciximab during percutaneous coronary intervention in patients with chronic renal insufficiency Academic Article